Senin, 03 Januari 2022

๐ŸŒŽ MarketBeat Daily Premium: Daily Analysts' Updates for 1/3/2022

Ratings changes for Pear Therapeutics, Vivid Seats, Cue Biopharma, Regeneron Pharmaceuticals, Exelon, Alnylam Pharmaceuticals, Cyxtera Technologies and more... View In Web Browser.
MarketBeat Daily Premium
VIEW MY PORTFOLIO right arrow
January 3rd, 2022
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Follow MarketBeat on StockTwits
S and P pricesDow pricesQQQ prices
Today's Top Stories
3 Volatile Stocks that Analysts Love
Germany calls nuclear power 'dangerous,' rejects EU plan
20 Best 5G Stocks to Buy Now (ad)
Contrarian Investing: Should You Use this Investment Strategy in 2022?
Kimberly Palmer: 5 steps to reach your money goals in 2022
3 Stocks Setting Up For More Growth In 2022
$29,000 for an average used car? Would-be buyers are aghast
CES gadget show stages a wary return amid COVID-19
Biden to meet with farmers as he seeks to cut meat prices
Turkey's inflation hits a 19-year high of 36%
Scientist, enforcer, high-flyer: 3 women put a mark on tech
Global stocks higher after Wall St ends 2021 with big gain
This Week: Job openings, Walgreens earns, nonfarm payrolls
Quick Links
Getting Started with MarketBeat All Access
completed Read Your Daily Newslettercompleted Check Out My MarketBeat
completed Watch Our Tutorial Videoscompleted Add a Stock to Your Watchlist
completed Set Up an Instant Alertcompleted View a Company's Profile Page
completed Customize Your Newsletternot completed View Current Brokerage Rankings
completed Check Out The Live News Feedcompleted Review Premium Reports
completed View The Idea Engine

Your Watchlist(s)
You have not added any stocks to your watchlist.

Click here to add stocks from your portfolio to your watchlist.



More Calendars from MarketBeat
U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume.

Export Data to Excel
MarketBeat Brokerage Ratings
Receive more information about MarketBeat's brokerage ratings and view the most recent ratings for all brokerages rated by MarketBeat.

CLICK HERE right arrow
Join Our Facebook Group
Join MarketBeat's free stock discussion and trading idea group on Facebook.

JOIN NOW right arrow

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
If you would like to make changes to your premium subscription, click here to manage your account or unsubscribe.

© 2006-2022 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: The Hottest "Next Gen Crypto" in the World Right Nowpixel

Tidak ada komentar:

Posting Komentar